Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06848192

The Parkinson's Disease Case-Control Study

The Parkinson's Disease Case-Control Study: Gut Microbiome Study for Parkinson's Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Westlake University · Academic / Other
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Accepted

Summary

The Parkinson's Disease Case-Control Study is a study of healthy volunteers and patients with Parkinson's disease aged 50-75 years living in Hangzhou, China. This study aims to systematically investigate the differences in intestinal fungi between patients and healthy volunteers, find the key strains, and explore the molecular mechanism of Parkinson's disease with multi-omics data. Another aim of this study is to explore the association between intestinal fungi and brain structure and function from the perspective of the gut-brain axis by combining brain image data.

Detailed description

Parkinson's disease is the second most common neurodegenerative disease of the central nervous system. Recent studies have shown that gut microorganisms, through their metabolites, can directly and indirectly affect brain function and neurodegenerative processes through the immune system, endocrine system, and nervous system, thus affecting the progress of Parkinson's disease. Gut fungi, as an important component of gut microorganisms, are rarely studied in Parkinson's disease. To systematically explore the differences in intestinal fungi between patients with Parkinson's disease and healthy volunteers, this project is expected to recruit 20 healthy volunteers and 20 Parkinson's disease patients respectively. The Parkinson's Disease Case-Control Study design incorporates collecting demographic information and clinical characteristics of Parkinson's disease patients and healthy volunteers, as well as biological samples (blood, urine, stool) and brain magnetic resonance imaging (MRI) of the subjects.

Conditions

Timeline

Start date
2025-03-05
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2025-02-26
Last updated
2025-06-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06848192. Inclusion in this directory is not an endorsement.